Details of the Drug

General Information of Drug (ID: DMFQXIP)

Drug Name
AZD9150
Indication
Disease Entry ICD 11 Status REF
Haematological malignancy 2B33.Y Phase 1/2 [1]
Cross-matching ID
TTD ID
D07RZW

References

1 Clinical pipeline report, company report or official report of ISIS Pharmaceuticals.